Axon's Q1 Earnings Top Estimates on Solid Software & Services Sales

Core Viewpoint - Axon Enterprise, Inc. reported strong first-quarter 2025 results, with adjusted earnings and revenues exceeding consensus estimates, driven by robust demand for its products and services [1][2]. Financial Performance - Adjusted earnings per share for Q1 2025 were $1.41, surpassing the Zacks Consensus Estimate of $1.27, marking a 22.6% year-over-year increase [1]. - Total revenues reached $603.6 million, exceeding the consensus estimate of $589 million and reflecting a 31.3% year-over-year growth [2]. Business Segment Performance - Connected Devices: Revenues increased by 26% year over year to $340.9 million, driven by demand for TASER 10 devices and Axon Body 4 [3]. - Software & Services: Revenues rose 39% year over year to $262.7 million, attributed to a growing user base and increased adoption of premium features [4]. Cost and Margin Analysis - Cost of sales increased by 18.2% year over year to $237.9 million, while total operating expenses climbed 54.7% to $374.5 million [5]. - Adjusted gross margin improved slightly to 63.6% from 63.2% in the previous year [5]. Balance Sheet and Cash Flow - Cash and cash equivalents at the end of Q1 2025 were $1.09 billion, up from $454.8 million at the end of 2024 [6]. - The company generated net cash of $25.8 million from operating activities, compared to a cash outflow of $15.9 million in the previous year [6]. Free Cash Flow - Adjusted free cash flow for the first three months of 2025 was $932 million, a significant increase from $32.1 million in the prior year [7]. Outlook for 2025 - Axon expects revenues to be between $2.60 billion and $2.70 billion, indicating approximately 27% year-over-year growth at the midpoint [8]. - Adjusted EBITDA is projected to be in the range of $650 million to $675 million, with an adjusted EBITDA margin of about 25% [8]. - Capital expenditures are anticipated to be between $160 million and $180 million, focusing on R&D and capacity expansion [9].